MAGE-1 (281-292)

MAGE-1 (281-292) is a synthetic peptide corresponding to amino acids 281 through 292 of the Melanoma Antigen Gene-1 (MAGE-1) protein, a member of the cancer-testis antigen family. As a peptide fragment derived from a tumor-associated protein, it plays a significant role in immunological and oncological research, particularly in studies related to antigen processing, T-cell epitope mapping, and peptide-MHC interaction analyses. The unique sequence of this peptide enables researchers to investigate specific immune responses and molecular recognition events that are central to tumor immunology and antigen-specific cellular assays.

Epitope mapping: Researchers utilize the MAGE-1 (281-292) peptide to delineate and characterize immunodominant epitopes recognized by cytotoxic T lymphocytes (CTLs) in the context of MHC class I molecules. By presenting this defined peptide to immune cells, investigators can identify specific T-cell receptors and elucidate the sequence motifs essential for antigen recognition, thereby advancing the understanding of tumor antigenicity and immune targeting.

Immunogenicity assessment: The peptide serves as a valuable tool for evaluating the immunogenic properties of tumor-associated antigens in vitro. It is commonly used in assays such as ELISPOT, intracellular cytokine staining, or T-cell proliferation assays to quantify and profile antigen-specific cellular immune responses. This application is crucial for validating the immunological relevance of candidate epitopes and for optimizing peptide-based immunological assays.

Peptide-MHC binding studies: The defined sequence of MAGE-1 (281-292) is frequently employed in binding assays to investigate its affinity and stability when complexed with various MHC class I alleles. Such studies are instrumental in determining the structural requirements for peptide loading, predicting population coverage of immune responses, and refining computational models of antigen presentation.

Functional T-cell activation assays: By using this peptide as a stimulus, researchers can activate antigen-specific T-cell populations in vitro, enabling functional analyses such as cytokine secretion profiling, cytotoxicity assays, and T-cell receptor (TCR) repertoire studies. These experiments are essential for dissecting the mechanisms of T-cell-mediated recognition and for evaluating the efficacy of immune modulation strategies in cancer research.

Peptide synthesis and analytical validation: The MAGE-1 (281-292) fragment also serves as a reference standard or model substrate in peptide synthesis and analytical workflows. Its well-characterized sequence supports method development in solid-phase peptide synthesis, purification optimization, and mass spectrometric identification. These applications facilitate quality control measures and support the advancement of peptide-based technologies in both research and industrial settings.

1. Multifunctional peptide-oligonucleotide conjugate promoted sensitive electrochemical biosensing of cardiac troponin I

2. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling

3. TMEM16F and dynamins control expansive plasma membrane reservoirs

4. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency

5. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation